Loading clinical trials...
Loading clinical trials...
This is a study to evaluate the pharmacokinetic characteristics and safety of IBI362 lyophilized powder and IBI362 liquid formulation in healthy Chinese male subjects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Innovent Biologics (Suzhou) Co. Ltd.
NCT07428187 · Overweight/Obesity
NCT07460856 · Overweight/Obesity, Metabolic Syndrome, and more
NCT03851627 · Fatty Liver, Overweight/Obesity, and more
NCT06822621 · Hypercholesterolemia, Overweight/Obesity
NCT06627569 · Overweight/Obesity, Stress
The Sceond Affiliated Hospital of Nanchang University
Nanchang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions